These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33237349)

  • 1. Let-7d inhibits intratumoral macrophage M2 polarization and subsequent tumor angiogenesis by targeting IL-13 and IL-10.
    Su B; Han H; Gong Y; Li X; Ji C; Yao J; Yang J; Hu W; Zhao W; Li J; Zhang G; Zhou L
    Cancer Immunol Immunother; 2021 Jun; 70(6):1619-1634. PubMed ID: 33237349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.
    Su B; Zhao W; Shi B; Zhang Z; Yu X; Xie F; Guo Z; Zhang X; Liu J; Shen Q; Wang J; Li X; Zhang Z; Zhou L
    Mol Cancer; 2014 Sep; 13():206. PubMed ID: 25193015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma.
    Zhao G; Na R; Li L; Xiao H; Ding N; Sun Y; Han R
    Oncol Rep; 2017 Aug; 38(2):1021-1028. PubMed ID: 28656230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.
    Fan B; Jin Y; Zhang H; Zhao R; Sun M; Sun M; Yuan X; Wang W; Wang X; Chen Z; Liu W; Yu N; Wang Q; Liu T; Li X
    Int J Oncol; 2020 Jan; 56(1):178-192. PubMed ID: 31789394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2.
    Mu L; Guan B; Tian J; Li X; Long Q; Wang M; Wang W; She J; Li X; Wu D; Du Y
    Oncol Rep; 2020 Nov; 44(5):1961-1970. PubMed ID: 32901879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of lncRNA-CRNDE in regulating tumour-associated macrophage M2 polarization and promoting tumour angiogenesis.
    Han C; Yang Y; Sheng Y; Wang J; Li W; Zhou X; Guo L
    J Cell Mol Med; 2021 May; 25(9):4235-4247. PubMed ID: 33742511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
    Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
    Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Gong X; Liu Y; Zhang Q; Liang K; Wei J; Du H
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
    Sato M; Nakai Y; Nakata W; Yoshida T; Hatano K; Kawashima A; Fujita K; Uemura M; Takayama H; Nonomura N
    PLoS One; 2013; 8(9):e74313. PubMed ID: 24073208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p/MLL3/GRHL2 signaling cascade.
    Zhang Y; Meng W; Yue P; Li X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):134. PubMed ID: 32660626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.
    Li J; Huang C; Zou Y; Ye J; Yu J; Gui Y
    Mol Cancer; 2020 Jun; 19(1):103. PubMed ID: 32503552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.
    Song H; Rao Y; Zhang G; Kong X
    Oncol Res; 2018 Apr; 26(3):457-466. PubMed ID: 28877780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.
    Chen F; Bai J; Li W; Mei P; Liu H; Li L; Pan Z; Wu Y; Zheng J
    PLoS One; 2013; 8(2):e56241. PubMed ID: 23457532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
    Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
    Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRP78 facilitates M2 macrophage polarization and tumour progression.
    Zhang H; Wang SQ; Hang L; Zhang CF; Wang L; Duan CJ; Cheng YD; Wu DK; Chen R
    Cell Mol Life Sci; 2021 Dec; 78(23):7709-7732. PubMed ID: 34713304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroartemisinin Prevents Progression and Metastasis of Head and Neck Squamous Cell Carcinoma by Inhibiting Polarization of Macrophages in Tumor Microenvironment.
    Chen R; Lu X; Li Z; Sun Y; He Z; Li X
    Onco Targets Ther; 2020; 13():3375-3387. PubMed ID: 32425545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.